Today’s guest on the ValueTheMarkets podcast is Dr Ray Barlow, CEO of E-Therapeutics (LSE:ETX). The company is employing a computer-based approach to the discovery of new drugs. It's Network-Driven Discovery (NDD) platform employs techniques such as machine learning, artificial intelligence, and data analysis to find better drug solutions in a more efficient manner.

In the interview, Ray discusses the NDD platform, the company’s business model, the changes he’s made since joining the board in 2017, and talks about his background in the industry.

Author: Stuart Langelaan

Disclosure:  The author was not paid for this piece.  The author does not own shares in the company mentioned.

All opinions expressed are those of ValueTheMarkets and the respective guests unless otherwise stated and should not be construed as investment advice or a recommendation to buy shares in any featured Company. Listeners are advised to do their own extensive research before buying shares which, as with all sm